AICLA
AICLA
Accidents Ischemiques Cerebraux Lies a l'Atherosclerose Study. A clinical trial that asked whether aspirin or aspirin + dipyridamole reduced the risk of fatal and nonfatal cerebral infarction compared with placebo.Conclusion Aspirin was much better than placebo; aspirin + dipyridamole was only marginally better than placebo.